Efficacy trials of Lassa Vaccines:endpoints, trial design, site selection

Overview

Participants reviewed available evidence on Lassa epidemiology and vaccine candidates, identified and discussed methodological options to evaluate vaccines, regardless of vaccine products, and agreed on some preliminary recommendations.

It was recognised both that the preliminary recommendations are likely to evolve as new evidence is generated and also, they must be tailored to the social and cultural context of affected communities.